Assessment of the factor of sepulcher bone separation in medication-related osteonecrosis of jaw

Assessment of the factor of sepulcher bone separation in medication-related osteonecrosis of jaw - Assessment of the factor of sepulcher bone separation in MRONJ

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058876

Enrollment

Registered

2025-08-24

Start date

2025-06-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medication-related osteonecrosis of jaw

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have been or are currently receiving oral or injectable bisphosphonates, anti-RANKL antibodies, anti-sclerostin antibodies, or parathyroid hormones for the treatment of osteoporosis or bone metastasis of cancer, and who will undergo sequestrectomy with a diagnosis of MRONJ.

Exclusion criteria

Exclusion criteria: If the patient (or legal representative) does not consent to the purpose of this study.

Design outcomes

Primary

Measure	Time frame
Identification of factors causing sepulchral bone separation.	—

Countries

Japan

Contacts

Public ContactOhba Seigo

Showa Medical University Department of Oral and Maxillofacial Surgery

sohba@dent.showa-i.ac.jp03-3787-1151

Outcome results